Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

lateral flow test

Sona Nanotech & GE Health Life Sciences partnership

Sona partners with GE Healthcare Life Sciences to complete Coronavirus Rapid Screening Test

Halifax, Nova Scotia, March 3, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences’ … Read More

Bond Digital Health & Sona Nanotech

Sona Announces Data Partnership for Covid-19 Rapid Screening Test

Halifax, Nova Scotia, February 18, 2020 – Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology company Bond Digital Health (Bond) to add data capture and analysis to its coronavirus (Covid-19) rapid screening test currently in … Read More

Sona Develops Rapid Screening Test for Coronavirus

  HALIFAX, Feb 10, 2020 — Sona Nanotech Inc. (“Sona”) (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, “nCoV19”. Sona is developing a quick-response lateral-flow test to screen patients … Read More

NativeAntigen & Sona Nanotech

Sona announces key partner for Coronavirus Rapid Screening Test

Halifax, Nova Scotia, Feb. 13, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) has secured an agreement with The Native Antigen Company (“Native”) to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona … Read More

Challenging the lateral flow sector at ALFC 2019

Last year Sona Nanotech attended the Advanced Lateral Flow Course as the ‘new kids on the block’, keen to show the lateral flow sector what we could do. Twelve months on and with a series of successful collaborations under our … Read More